Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey

Abstract

Objective:

We assessed umbilical cord tissue as a means of detecting fetal exposure to five classes of drugs of abuse.

Study Design:

In a multicentered study in Utah and New Jersey, we collected umbilical cord tissue when high-risk criteria were met for maternal illicit drug use. The deidentified umbilical cord specimens were analyzed for five drug classes: methamphetamine, opiates, cocaine, cannabinoids and phencyclidine. For each umbilical cord specimen, an enzyme-linked immunosorbent assay (ELISA)-based screening test was compared with a ‘gold standard’ test, consisting of gas or liquid chromatography tandem mass spectrometry.

Result:

A total of 498 umbilical cord samples were analyzed of which 157 (32%) were positive using mass spectrometric detection. The sensitivity and specificity of the ELISA-based test for each class of drugs tested were as follows: methamphetamine 97 and 97%, opiates 90 and 98%, cocaine 90 and 100%, cannabinoids 96 and 98% and phencyclidine (only 1 of the 498 umbilical cord sample was positive for phencyclidine) 100 and 100%.

Conclusion:

We judge that the performances of the ELISA-based tests are sufficient for clinical testing of fetal exposure to methamphetamine, opiates, cocaine and cannabinoids. Studies obtained on umbilical cord tissue can result in a more rapid return to the clinician than meconium testing, because waiting for meconium to be passed sometimes requires many days. Moreover, in some cases the meconium is passed in utero making collection impossible, whereas umbilical cord tissue should always be available for drug testing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD . Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J Perinatol 2006; 26: 11–14.

    Article  CAS  Google Scholar 

  2. Le NL, Reiter A, Tomlinson K, Jones J, Moore C . The detection of oxycodone in meconium specimens. J Anal Toxicol 2005; 29: 54–57.

    Article  CAS  Google Scholar 

  3. Zweig MH, Campbell G . Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561–577.

    CAS  Google Scholar 

  4. Addis A, Moretti ME, Ahmed SF, Einarson TR, Koren G . Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 2001; 15: 341–369.

    Article  CAS  Google Scholar 

  5. Church MW, Morback CA, Subramanian MG . Comparative effects of prenatal cocaine, alcohol, and undernutrition on maternal/fetal toxicity and fetal body composition in the Sprague–Dawley rat with observations on strain-dependent differences. Neurotoxicol Teratol 1995; 17: 559–567.

    Article  CAS  Google Scholar 

  6. Fried RA, Watkinson B . 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J Dev Behav Pediatr 1990; 11: 49–58.

    Article  CAS  Google Scholar 

  7. Goldschmidt L, Day NL, Richardson GA . Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22: 325–336.

    Article  CAS  Google Scholar 

  8. Oro AS, Dixon SD . Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987; 111: 571–578.

    Article  CAS  Google Scholar 

  9. Plessinger MA . Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998; 25: 119–138.

    Article  CAS  Google Scholar 

  10. Dixon SD, Bejar R . Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989; 115: 770–778.

    Article  CAS  Google Scholar 

  11. Gareri J, Klein J, Koren G . Drugs of abuse testing in meconium. Clinica Chimica Acta 2006; 366: 101–111.

    Article  CAS  Google Scholar 

  12. Ostrea Jr EM, Brady MJ, Parks PM, Asensio DC, Naluz A . Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr 1989; 115: 474–477.

    Article  Google Scholar 

  13. Ostrea Jr EM, Romero A, Yee H . Adaptation of the meconium drug test for mass screening. J Pediatr 1993; 122: 152–154.

    Article  Google Scholar 

  14. Moore C, Negrusz A, Lewis D . Determination of drugs of abuse in meconium. J Chromatogr B Biomed Sci Appl 1998; 713: 137–146.

    Article  CAS  Google Scholar 

  15. Ostrea Jr EM, Brady M, Gause S, Raymundo AL, Stevens M . Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992; 89: 107–113.

    PubMed  Google Scholar 

  16. Moriya F, Chan KM, Noguchi TT, Wu PY . Testing for drugs of abuse in meconium of newborn infants. J Anal Toxicol 1994; 18: 41–45.

    Article  CAS  Google Scholar 

  17. Ostrea Jr EM, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001; 138: 344–348.

    Article  CAS  Google Scholar 

  18. Bar-Oz B, Klein J, Karaskov T, Koren G . Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003; 88: F98–F100.

    Article  CAS  Google Scholar 

  19. Vinner E, Vignau J, Thibault D, Codaccioni X, Brassart C, Humbert L et al. Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome. Ther Drug Monit 2003; 25: 421–432.

    Article  CAS  Google Scholar 

  20. Garcia-Bournissen F, Rokach B, Karaskov T, Koren G . Cocaine detection in maternal and neonatal hair: implications to fetal toxicology. Ther Drug Monit 2007; 29: 71–76.

    Article  CAS  Google Scholar 

  21. Ostrea Jr EM, Romero A, Knapp DK, Ostrea AR, Lucena JE, Utarnachitt RB . Postmortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: clinical implications. J Pediatr 1994; 124: 477–479.

    Article  Google Scholar 

  22. Silvestre MA, Lucena JE, Roxas Jr R, Evangelista ES, Ostrea Jr EM . Effects of timing, dosage, and duration of morphine pregnancy on the amount of morphine in meconium in a rat model. Biol Neonate 1997; 72: 112–117.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the nurses of the Labor and Delivery Units and the Neonatal Intensive Care Units at Logan Regional, McKay-Dee, LDS and University Hospital, UMDNJ, for their valuable assistance in collecting the umbilical cord specimens for this study. This work was supported by grant 2 R44 DA017412-02A1 from the National Institute of Drug Abuse.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R D Christensen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montgomery, D., Plate, C., Jones, M. et al. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. J Perinatol 28, 750–753 (2008). https://doi.org/10.1038/jp.2008.97

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2008.97

Keywords

This article is cited by

Search

Quick links